These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5264689)

  • 1. The effect of diphenylhydantoin and phenobarbital on the liver of the pig.
    Dam M; Moller JE; Petersen P
    Epilepsia; 1969 Dec; 10(4):507-19. PubMed ID: 5264689
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of diphenylhydantoin and phenobarbital on the hydroxyproline contents of skin in pigs.
    Dam M; Langgård H
    Acta Neurol Scand; 1969; 45(4):502-6. PubMed ID: 5806781
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of folic acid on the anticonvulsive action of phenobarbital and diphenylhydantoin.
    Czarnecka E; Zajac A; Malafiej E; Dramiński M
    Acta Physiol Pol; 1975; 26(2):183-8. PubMed ID: 1146565
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of phenobarbital on plasma diphenylhydantoin level and metabolism in man and in rat liver microsomes.
    Kutt H; Haynes J; Verebely K; McDowell F
    Neurology; 1969 Jun; 19(6):611-6. PubMed ID: 5814306
    [No Abstract]   [Full Text] [Related]  

  • 5. [Quantitative change in the activity of lysosomal enzymes in the induced rat liver].
    Hornef W
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):361-2. PubMed ID: 4253799
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhancement by phenobarbital and diphenylhydantoin of carbon monoxide production in normal man.
    Coburn RF
    N Engl J Med; 1970 Sep; 283(10):512-5. PubMed ID: 5434134
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased metabolism of metyrapone in rats pretreated with diphenylhydantoin or phenobarbital.
    Szeberenyi S; Tacconi MT; Garattini S
    Endocrinology; 1969 Sep; 85(3):575-6. PubMed ID: 5793035
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of phenobarbital and diphenylhydantoin on different lipid fractions of liver].
    Ariyoshi T; Remmer H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):90-1. PubMed ID: 4239254
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatic drug metabolism after phenobarbital and diphenylhydantoin administration in the rat--influence of vitamin D3 status.
    Gascon-Barré M; Côte MG; Brodeur J
    Biochem Pharmacol; 1979; 28(2):313-9. PubMed ID: 218591
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of vitamin D3 status, phenobarbital, and diphenylhydantoin treatment on the plasma 25-hydroxyvitamin D3 concentrations in the rat.
    Gascon-Barré M; Delvin EE; Glorieux FH; Côté MG
    Can J Physiol Pharmacol; 1981 Oct; 59(10):1073-81. PubMed ID: 6274489
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of phenobarbital treatment on lysosomal enzyme activity in rat liver.
    Mulder GJ
    Biochem Pharmacol; 1971 Jun; 20(6):1328-31. PubMed ID: 4330205
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects induced by phenobarbital and phenytoin on the activity of pseudocholinesterase in serum and liver in the mouse.
    Puche E; García de la Serrana H; Mota C
    Pharmacol Toxicol; 1990 Jul; 67(1):91-2. PubMed ID: 2395824
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the mechanism of action of mammalian hepatic azoreductase. II. The effects of phenobarbital and 3-methylcholanthrene on carbon monoxide sensitive and insensitive azoreductase activities.
    Hernandez PH; Mazel P; Gillette JR
    Biochem Pharmacol; 1967 Oct; 16(10):1877-88. PubMed ID: 4383668
    [No Abstract]   [Full Text] [Related]  

  • 14. 5,5'-Diphenyl-2-thiohydantoin (DPTH): an inducer of microsomal drug-metabolizing enzymes.
    Dalton C; Kamm JJ; Bartl P
    J Pharmacol Exp Ther; 1972 Sep; 182(3):491-9. PubMed ID: 5055407
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serum beta-glucuronidase activity in patients treated with phenobarbital and diphenylhydantoin].
    Tutor JC; Fernández MP; Paz JM
    Arch Farmacol Toxicol; 1982 Apr; 8(1):37-44. PubMed ID: 7138085
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticonvulsant drug mechanisms. Phenytoin, phenobarbital, and ethosuximide and calcium flux in isolated presynaptic endings.
    Sohn RS; Ferrendelli JA
    Arch Neurol; 1976 Sep; 33(9):626-9. PubMed ID: 962645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of phenytoin and phenobarbital in terms of order and temporal spacing of administration in monkeys.
    Lockard JS; Levy RH; Uhlir V; Farquhar JS
    Epilepsia; 1976 Dec; 17(4):481-5. PubMed ID: 826397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological influences on T4 to T3 conversion in rat liver.
    Hüfner M; Knöpfle M
    Clin Chim Acta; 1976 Nov; 72(3):337-41. PubMed ID: 975586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative enhancing effects of phenobarbital, amobarbital, diphenylhydantoin, and dichlorodiphenyltrichloroethane on 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat.
    Peraino C; Fry RJ; Staffeldt E; Christopher JP
    Cancer Res; 1975 Oct; 35(10):2884-90. PubMed ID: 1157054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticonvulsant activity of phenobarbital and phenytoin in combination.
    Leppik IE; Sherwin AL
    J Pharmacol Exp Ther; 1977 Mar; 200(3):570-5. PubMed ID: 850129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.